筛查检出肺癌的形态学观察者间一致性:超越肺结节与肿块
四名胸部影像经验不同的放射科医生回顾性判读273例低剂量CT筛查检出的肺癌,评估其形态是否符合Fleischner学会肺结节或肿块定义。241/273(88%)完全一致判定为结节或肿块,20/273(7.3%)判定为非结节/非肿块(NN/NM);形态分类总体一致性极好(261/273,96%,κ=0.85),亚分类一致性也极好(18/20,90%,κ=0.93)。
要点
- 筛查检出肺癌中7.3%(20/273)在低剂量CT上不表现为结节或肿块,形态分类一致性极好(96%,κ=0.85)。
- NN/NM病变完全一致亚分类包括囊腔相关6例、瘢痕样6例、支气管内5例、其他未定义1例。
- 认识肺癌多种低剂量CT表现有助于避免漏诊或延迟诊断。
核心结论
- 相当比例筛查检出肺癌在低剂量CT上呈非结节/非肿块表现,但观察者间形态分类一致性极好;认识多种表现可避免漏诊或延迟诊断。
研究设计与样本
- 回顾性研究,4名胸部影像经验不同的放射科医生判读273例筛查检出的肺癌,以Fleischner学会肺结节或肿块定义为参考。
关键影像表现/征象
- 241/273(88%)病变经完全一致判定为肺结节或肿块。
- 20/273(7.3%)病变经完全一致判定为非结节/非肿块(NN/NM)。
- NN/NM亚分类完全一致:囊腔相关6例(2.2%)、瘢痕样6例(2.2%)、支气管内5例(1.8%)、其他未定义1例(0.7%)。
诊断标准与关键数值
- 形态符合Fleischner学会肺结节或肿块定义者判为结节/肿块,不符合者判为NN/NM并亚分类为囊腔相关、条纹样、瘢痕样、支气管内或其他未定义。
- 形态定义一致性:261/273(96%,95%CI 92-98%),κ=0.85(95%CI 0.75-0.92)。
- NN/NM亚分类一致性:18/20(90%,95%CI 68-99%),κ=0.93(95%CI 0.86-1.00)。
- 4.4%(12/273)病例形态学判定未达完全一致。
临床应用与阅片要点
- 阅片时需注意筛查检出肺癌可表现为囊腔相关、条纹样、瘢痕样、支气管内等非结节/非肿块形态。
- 对低剂量CT上各种局灶性异常保持警觉,有助于避免漏诊或延迟诊断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Pulmonary nodules and masses are the typical presentations of lung cancer. However, a spectrum of focal opacities cannot be defined as either "pulmonary nodule" or "mass," despite representing cancer. We aimed to assess the morphology of screening-detected lung cancers at low-dose computed tomography LDTC and to evaluate inter-observer agreement in their classification.
METHODS: Four radiologists with different experiences in thoracic imaging retrospectively reviewed 273 screening-detected lung cancers. Readers were asked to assess if morphology at the time of diagnosis was consistent with the Fleischner Society definition of pulmonary "nodule" or "mass." Cancers not consistent were defined as "non-nodular/non-mass" (NN/NM) and sub-classified as follows: associated with cystic airspaces, stripe-like, scar-like, endobronchial, or not otherwise defined (NOD). Inter-observer agreement was evaluated using Cohen's K statistic among pairs of readers and modified Fleiss' kappa statistic for overall agreement.
RESULTS: Two hundred forty-one of the 273 (88%) lesions were defined as pulmonary nodule or mass by complete agreement, while 20/273 (7.3%) were defined as NN/NM. Six (2.2%) of 273 were sub-classified as lesions associated with cystic airspace, six (2.2%) as scar-like, five (1.8%) as endobronchial, and one (0.7%) as NOD by complete agreement. The concordance in defining morphology was excellent (261/273; 96%, 95%CI 92-98%; k 0.85, 95%CI 0.75-0.92) and also in the sub-classification (18/20; 90%, 95%CI 68-99%, k 0.93, 95%CI 0.86-1.00). There was incomplete agreement regarding lesion morphology in 4.4% (12/273) of cases.
CONCLUSIONS: A non-negligible percentage of screening-detected lung cancers has a NN/NM appearance at LDCT. The concordance in defining lesion morphology was excellent. The awareness of various presentations can avoid missed or delayed diagnosis.
KEY POINTS: • A non-negligible percentage of screening-detected lung cancers have neither nodular nor mass appearance at low-dose CT. • The awareness of various LDCT presentations of lung cancer can avoid missed or delayed diagnosis. • Optimal protocol management in CT screening should take into consideration lung nodules as well as various other focal abnormalities.
引用
- Rampinelli C, Minotti M, Ancona E, et al. Inter-observer agreement on the morphology of screening-detected lung cancer: beyond pulmonary nodules and masses. Eur Radiol. 2019. PMID: 31062136. doi:10.1007/s00330-019-06243-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。